Status:
COMPLETED
Magnitude of Osteoarthritis disadVantage on pEoples liveS
Lead Sponsor:
AstraZeneca
Conditions:
Osteoarthritis
Eligibility:
All Genders
45+ years
Brief Summary
Estimate the prevalence of self-reported osteoarthritis and its characterization in adults over 45 years of age: * Characterization of self-reported patients with OA (socio-demographic, comorbidities...
Detailed Description
Magnitude of Osteoarthritis disadvantage on peoples lives.
Eligibility Criteria
Inclusion
- \- Adults over 45 years old with self-reported osteoarthritis
Exclusion
- \- NA
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
1015 Patients enrolled
Trial Details
Trial ID
NCT01423097
Start Date
September 1 2011
End Date
November 1 2011
Last Update
October 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Queluz Baixo, Barcarena, Portugal